Information Provided By:
Fly News Breaks for February 17, 2017
CC
Feb 17, 2017 | 08:28 EDT
As reported previously, Susquehanna analyst Don Carson upgraded Chemours to Positive from Neutral citing significant upside he sees to management's modest EBITDA guidance due to greater momentum in TiO2 prices. He noted the prices are at the beginning of a multi-year cyclical rebound, while there will be continued structural cost reductions, faster adoption of Opteon refrigerant, and reduced litigation risk. Carson raised his price target to $40 from $26 on Chemours shares.